Search

everythinglearnresearchcommunity

for

Search:↓

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Mesenchymal stem cells show promise for effective skin repair and regeneration.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Men and women react differently to opioids, with hormones potentially influencing these differences.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The mini-lift is a less invasive face-lift for younger patients that is quicker, cheaper, and has a fast recovery, but is less effective for the midface and excessive neck skin.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Wild African goats have genetic adaptations for surviving harsh desert conditions.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.